Navigation Links
ITC Acquires Accumetrics to Form Leading POC Cardiovascular Diagnostics Business
Date:8/30/2013

PISCATAWAY, N.J. and SAN DIEGO, Aug. 30, 2013 /PRNewswire/ -- ITC Nexus Holding Company (ITC), a global leader in hemostasis management and Point-of-Care (POC) testing, today announced it has acquired Accumetrics, a global leader in assessing patient response to all major antiplatelet therapies. Terms of the transaction were not disclosed.

ITC develops, manufactures, and markets the Hemochron® product line, a market-leading POC system used to measure clotting activity for patients undergoing anticoagulation therapy.  Accumetrics develops, manufactures, and markets the VerifyNow® product line, a market-leading POC system used to measure platelet reactivity following antiplatelet therapies, including ADP receptor antagonists and aspirin.

"ITC has a history of innovation and leadership in Point-of-Care coagulation testing and Accumetrics is a pioneer and leader in Point-of-Care platelet function testing," said John Sperzel, Chief Executive Officer (CEO) of ITC. "The combination of ITC's Hemochron® and Accumetrics' VerifyNow® product lines creates a leading hospital-based POC cardiovascular diagnostics business."

"Accumetrics has played a leading role in the development of the antiplatelet monitoring market. The performance of the VerifyNow system has been demonstrated in numerous clinical studies, and we have thousands of satisfied customers around the world," said Accumetrics Chief Executive Officer Timothy I. Still. "I am confident that combining Accumetrics with ITC provides the best opportunity to accelerate the global adoption of the VerifyNow system."

Mr. Sperzel will serve as CEO of the combined company and Greg Tibbitts, Chief Financial Officer of Accumetrics, will serve as CFO of the combined company. Now that the transaction has closed, the process of integrating the ITC and Accumetrics businesses will begin immediately and the leadership teams will work closely to insure a seamless transition for customers. 

The combined company will assume a new name, Accriva Diagnostics, and its corporate headquarters will be established in San Diego. 

Jefferies LLC served as the exclusive financial advisor to Accumetrics and Cooley LLP served as its legal advisor. Willkie Farr & Gallagher LLP served as ITC's legal advisor.

About ITC
ITC is a world leader in the fields of hemostasis management and POC testing with over 40 years of knowledge and experience. ITC develops, manufactures, and markets: Hemochron® and ProTime® POC coagulation systems; IRMA TruPoint® Blood Gas and Electrolyte systems; Avoximeter® CO-Oximetry systems; and Tenderfoot®, Tenderlett® and Surgicutt® skin incision products. For more product information, go to www.itcmed.com

About Accumetrics
Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.  Accumetrics' VerifyNow System® is the first rapid and easy-to-use platform to help physicians determine an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including FDA-cleared products for aspirin, P2Y12 inhibitors (e.g. prasugrel (Effient®) and clopidogrel (Plavix®)), and GP IIb/IIIa inhibitors (e.g. ReoPro® and Integrilin®), the VerifyNow System® provides valuable information to help physicians make informed treatment decisions. For more information about Accumetrics and its products, visit www.accumetrics.com

Media Contact
Kim Ballard, ITC Nexus Dx
Tel: 1 732.548.5700 ext. 4149


'/>"/>
SOURCE ITC Nexus Holding Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property for Ophthalmic Compound Development Opportunity
2. IDEXX Laboratories Acquires Brazil Distributor
3. Arcturus Therapeutics Acquires Cutting-Edge UNA Patent Estate from Marina Biotech
4. Levine Leichtman Acquires Champion Manufacturing
5. BC Technical Acquires C&G Technologies
6. FMC Corporation Acquires Leading High-Purity Omega-3 Concentrates Producer Epax AS
7. Bausch + Lomb Acquires Option to License New Compound to Treat Dry Eye Syndrome (DES)
8. Integrated Solutions Group, Inc. Acquires California-based Data Strategies, Inc.
9. Belrose Pharma Acquires Enzons Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies
10. Perrigo Company Acquires Ophthalmic Product Portfolio From Fera Pharmaceuticals, LLC For An Upfront Payment Of $93 Million
11. Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , Deutschland und GERMANTOWN, Maryland ... Zusammenarbeit mit Therawis bedient ... bei Brustkrebs   QIAGEN N.V. (NASDAQ: ... gab heute bekannt, eine Lizenz- und Entwicklungsvereinbarung mit ... Assays für die Onkologie eingegangen zu sein. Ein ...
(Date:5/25/2016)... YORK , May 25, 2016  According to ... reached $381 billion in 2015.  Though these are ... plenty of opportunity for success for companies that ... in search of new growth prospects medical device ... on research and development (R&D) than do companies ...
(Date:5/25/2016)... NORTH CHESTERFIELD, Va. , May 25, 2016 ... commercially-available next-generation sequencing test for wounds and infections. ... fungi, ALL parasites, and select viruses. The test ... infected area. David G. ... advanced molecular testing to facilitate wound healing: "We ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... , ... Aimed at nurses and employees in the health care world, this ... the nursing and health care industry. It also provides insight to the developing trends ... , As the nursing industry is coming out of one of the biggest recessions ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media ... Janet Yellen and company to wait until March 2017 for an interest rate increase, ... Mack Robinson College of Business. , “The Federal Open Market Committee (FOMC) dot charts ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, and ... according to court documents and SEC filings. A jury has returned a ... American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded ...
(Date:5/26/2016)... ... , ... Connor Sports, through its Connor Cares initiative, will continue ... Catchings Legacy Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and ... forms and levels of the game, Connor Sports has committed to a significantly increased ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac arrhythmia is ... impact on long-term patient survival, reports a team of UPMC researchers in the ... in the Journal of Thoracic and Cardiovascular Surgery, provide critical information that will ...
Breaking Medicine News(10 mins):